Thiem D Phan

Array ( [id] => 8140893 [patent_doc_number] => 20120094998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates' [patent_app_type] => utility [patent_app_number] => 13/264662 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29078 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094998.pdf [firstpage_image] =>[orig_patent_app_number] => 13264662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768429 [patent_doc_number] => 20120035372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => ' METHOD FOR PRODUCING 2-HALOGENO-6-SUBSTITUTED-4-TRIFLUOROMETHYLPYRIDINE' [patent_app_type] => utility [patent_app_number] => 13/264553 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6311 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035372.pdf [firstpage_image] =>[orig_patent_app_number] => 13264553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744945 [patent_doc_number] => 20120022271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'NOVEL METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/259640 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5880 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022271.pdf [firstpage_image] =>[orig_patent_app_number] => 13259640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4585339 [patent_doc_number] => 07851636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Heteroaryl-ureas and their use as glucokinase activators' [patent_app_type] => utility [patent_app_number] => 12/757217 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85417 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851636.pdf [firstpage_image] =>[orig_patent_app_number] => 12757217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128509 [patent_doc_number] => 20120088808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'CRYSTAL FORMS OF SAXAGLIPTIN' [patent_app_type] => utility [patent_app_number] => 13/262652 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7357 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088808.pdf [firstpage_image] =>[orig_patent_app_number] => 13262652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7683668 [patent_doc_number] => 20100240743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'CANNABINOID RECEPTOR MODULATOR' [patent_app_type] => utility [patent_app_number] => 12/756896 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 154945 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240743.pdf [firstpage_image] =>[orig_patent_app_number] => 12756896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413114 [patent_doc_number] => 08697150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Process of extracting isothiocyanates' [patent_app_type] => utility [patent_app_number] => 12/750999 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11327 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12750999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496627 [patent_doc_number] => 08735442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Composition for alleviating ultraviolet radiation-induced damage' [patent_app_type] => utility [patent_app_number] => 13/138786 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 10807 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13138786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669502 [patent_doc_number] => 20110318771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'DEUTERIUM ISOBARIC TAG REAGENTS FOR QUANTITATIVE ANALYSIS' [patent_app_type] => utility [patent_app_number] => 13/255849 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10798 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791662 [patent_doc_number] => 20120053218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'TRIAZOLE DERIVATIVES AS VASOPRESSIN-RECEPTOR INHIBITORS FOR TREATING CARDIAC INSUFFICIENCY' [patent_app_type] => utility [patent_app_number] => 13/255515 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24663 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053218.pdf [firstpage_image] =>[orig_patent_app_number] => 13255515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831661 [patent_doc_number] => 08859830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Methods and assemblies for liquid-phase reactions' [patent_app_type] => utility [patent_app_number] => 12/717800 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5326 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12717800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056547 [patent_doc_number] => 20120077990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Alkene Aziridination' [patent_app_type] => utility [patent_app_number] => 13/202804 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14275 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077990.pdf [firstpage_image] =>[orig_patent_app_number] => 13202804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514940 [patent_doc_number] => 20100216762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/703615 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41141 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216762.pdf [firstpage_image] =>[orig_patent_app_number] => 12703615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249172 [patent_doc_number] => 20100137316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/702383 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 45310 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137316.pdf [firstpage_image] =>[orig_patent_app_number] => 12702383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043603 [patent_doc_number] => 20120071536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'N-[(2-AZABICYCLO[2.1.1]HEX-1-YL)-ARYL-METHYL]-BENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/148583 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10018 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071536.pdf [firstpage_image] =>[orig_patent_app_number] => 13148583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446301 [patent_doc_number] => 20100144762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'NOVEL SULFONAMIDES AS L-CPT1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/701769 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12845 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144762.pdf [firstpage_image] =>[orig_patent_app_number] => 12701769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568027 [patent_doc_number] => 20110288090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Inhibitors of AKT Activity' [patent_app_type] => utility [patent_app_number] => 13/147392 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74824 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288090.pdf [firstpage_image] =>[orig_patent_app_number] => 13147392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587418 [patent_doc_number] => 20110281928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof' [patent_app_type] => utility [patent_app_number] => 13/145563 [patent_app_country] => US [patent_app_date] => 2010-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10577 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281928.pdf [firstpage_image] =>[orig_patent_app_number] => 13145563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993564 [patent_doc_number] => 20110015217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Pro-Neurogenic Compounds' [patent_app_type] => utility [patent_app_number] => 12/685652 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 50876 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015217.pdf [firstpage_image] =>[orig_patent_app_number] => 12685652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186617 [patent_doc_number] => 20120115840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BENZYL]-AZETIDINE-3-CARBOXYLIC ACID' [patent_app_type] => utility [patent_app_number] => 13/140478 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15403 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115840.pdf [firstpage_image] =>[orig_patent_app_number] => 13140478 [rel_patent_id] =>[rel_patent_doc_number] =>)